Tred Avon Family Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
22,926
+1,347
+6% +$77.3K 0.4% 60
2026
Q1
$1.31M Buy
21,579
+3,568
+20% +$208K 0.43% 55
2025
Q4
$971K Sell
18,011
-569
-3% -$27.4K 0.32% 80
2025
Q3
$838K Buy
+18,580
New +$868K 0.29% 96

Other funds holding BMY

Tred Avon Family Wealth's BMY Position: Q2 2026 in Review

Tred Avon Family Wealth increased its Bristol-Myers Squibb (BMY) stake by 6.2% in Q2 2026, buying an estimated $77.3K and bringing the position to 22,926 shares worth $1.32M. The position accounts for 0.4% of the portfolio, ranked #60.

Tred Avon Family Wealth first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Tred Avon Family Wealth held 22,926 shares of Bristol-Myers Squibb worth $1.32M as of Q2 2026.
  • Tred Avon Family Wealth bought 1,347 Bristol-Myers Squibb shares in Q2 2026, an estimated $77.3K.
  • Bristol-Myers Squibb made up 0.4% of Tred Avon Family Wealth's portfolio in Q2 2026, its #60 holding.
  • Tred Avon Family Wealth first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Tred Avon Family Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.